Pure Global
NCT06231732

The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study

The Impact of High-frequency Transcranial Alternating Current Stimulation (Hi-tACS) on Cognitive Function in Patients With Schizophrenia: a Pilot Study
Sir Run Run Shaw Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Schizophrenia
Drug/Device/Intervention
high-frequency transcranial alternating current stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Sir Run Run Shaw Hospital
Location
Hanzhou, China
Timeline & enrollment
Phase
N/A
Start date
Nov 14, 2023
End date
Jun 01, 2024
Enrollment
12 participants
Primary outcome

scores of Repeatable Battery for the Assessment of Neuropsychological Status,functional near-infrared spectroscopy

Summary

This study is a double-blind, randomized, controlled intervention study aimed at exploring
 whether high-frequency transcranial alternating current stimulation (Hi-tACS) can improve
 cognitive impairment in patients with schizophrenia.

ICD-10 classifications
SchizophreniaSimple schizophreniaSchizophrenia, unspecifiedOther schizophreniaParanoid schizophrenia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06231732
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06231732 through Pure Global AI's free database. This phase not specified trial is sponsored by Sir Run Run Shaw Hospital and is currently Recruiting. The study focuses on Schizophrenia. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.